Mark Dehdashtian is a product development leader with decades of experience developing disruptive technologies and bringing new therapies to market to help patients address unmet medical needs. He serves as the Executive Vice President of DiNAQOR’s Medical Device division.
Mr. Dehdashtian spent 25 years in leadership roles at Edwards Lifesciences, including serving as the company’s Vice President of Research and Development for its Heart Valve Therapy, Advanced Technology and Cardiac Surgery Systems divisions. At Edwards, Mr. Dehdashtian designed the delivery systems for transcatheter heart valves and was instrumental in commercializing the transcatheter heart valve transapical systems.
He holds more than 60 U.S. patents as well as many international patents, most notably for the design of the transcatheter heart valve, and his work has been published in several peer-reviewed journals. Mr. Dehdashtian has also served as a member of medical technology steering committees to develop industry-wide standards.
He obtained a MS in Technology Management from Pepperdine Graziadio Business School.